Interesting Results from the Propecia Twin Study
Interesting Results from the Propecia Twin Study
Nine pairs of male identical twins, over a span of one year, participated in the Propecia twin study. The main goal of the Propecia twin study was to see how effective Propecia was at treating male pattern hair loss. Propecia was compared to a placebo that was also given to some of the participants in the study.
The Propecia twins research was a random, placebo-controlled study that was double-blind. This means that the participants and the doctors had no clue who was receiving Propecia, an effective hair loss treatment, or a placebo. In the study, one of the twins would take a placebo, designed to look like Propecia, and the other twin took the real Propecia tablet.
Both of the twins had to be in the same stage of male pattern hair loss, according to the Norwood-Hamilton Scale. The results were measured by hair counts and by viewing before and after pictures, otherwise known as a photographic study. After one year. the photographic measurements proved that the group that was taking Propecia daily had improvements.
Everyone who had taken Propecia in the study had not lost any more hair. However, the placebo group still suffered from further hair loss. This is one of the prime examples that Propecia is a successful treatment that prevents a man from losing any more hair. Also, in a percentage of cases, the growth of new hair occurred. The Propecia twin study was an effective way to prove, once-again, the great results of Propecia.